Alnylam Pharmaceuticals
ALNY
#565
Rank
ยฃ28.10 B
Marketcap
ยฃ217.07
Share price
-3.35%
Change (1 day)
80.40%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company